Related Experiment Video

Updated: Sep 17, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

PSMA PET or conventional imaging in metastatic hormone-sensitive prostate cancer?

Panagiotis J Vlachostergios1,2

  • 1Department of Medical Oncology, IASO Thessalias Hospital, Larissa, Greece.

Expert Review of Anticancer Therapy
|July 4, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Prostate specific membrane antigenbiomarkershormone-sensitive prostate cancerimagingtumor volume

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

382

Related Experiment Videos

Last Updated: Sep 17, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

382

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

5.8K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.8K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

239
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
239

Articles linked to this work by shared authors, journal, and citation graph.

Incorporating Metastatic Disease Burden into Prognostic Assessment in Metastatic Castration-Resistant Prostate Cancer: The MIRA Score.

Cancers·2026

Inflammatory and Nested Testicular Sex Cord Tumors: Clinical and Molecular Characterization.

Genes·2026

Cancer vaccines: advances, hurdles, and future directions.

Exploration of targeted anti-tumor therapy·2025

Neuraxial Anesthesia and Cancer Recurrence Following Prostatectomy: Thinking Outside the Box.

Pharmacy (Basel, Switzerland)·2025

Association of KIM-1 (HAVCR1) Expression with the Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.

Current gene therapy·2025

Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre.

Cancers·2025

From fragmentation to focus: building collaborative networks for rare cancer research - the Italian TYME network as a model for care and innovation?

Expert review of anticancer therapy·2026

Conversion surgery for advanced biliary tract cancer in the era of molecularly targeted therapy and immunotherapy: from unresectable disease to multidisciplinary curative strategy.

Expert review of anticancer therapy·2026

AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management.

Expert review of anticancer therapy·2026

Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing.

Expert review of anticancer therapy·2026

The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches.

Expert review of anticancer therapy·2026

Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection.

Expert review of anticancer therapy·2026

Porous skeletal lesions in perspective: The role of radiology and microscopy for paleopathological analysis.

International journal of paleopathology·2026

Navigating PI-RADS 3 Lesions: Reducing Uncertainty and Guiding Prostate Cancer Diagnostic Decision Making.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026

Bone mineral density in participants with phenylalanine hydroxylase (PAH) deficiency: a report from the PHEFREE rare disorders consortium.

Molecular genetics and metabolism·2026

To Evaluate Efficacy of Intralesional Platelet-Rich Plasma in Patients with Plantar Fasciitis.

Journal of the American Podiatric Medical Association·2026

Hormonal profiles of men with highly elevated SHBG and primary testicular dysfunction support free hormone hypothesis.

Journal of the Endocrine Society·2026

Fresh frozen plasma pleurodesis for bronchopleural fistula following secondary spontaneous pneumothorax due to ruptured emphysematous bullae in a high-risk elderly COPD patient.

Respiratory medicine case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us